Fujii H - Search Results

1

Gynecologic malignancies accompanied by benign hormone-dependent diseases.

Koshiyama M, Morita Y, Fujii H, Kobashi Y, Yoshida M. Koshiyama M, et al. Among authors: fujii h. Menopause. 2001 Summer;8(2):149-50. doi: 10.1097/00042192-200103000-00011. Menopause. 2001. PMID: 11256876

2

Expression of multidrug resistance-associated protein in endometrial carcinomas: correlation with clinicopathology and prognosis.

Koshiyama M, Yoshida M, Fujii H, Konishi M, Nanno H, Hayashi M, Tauchi K. Koshiyama M, et al. Among authors: fujii h. Ann Diagn Pathol. 1999 Apr;3(2):81-7. doi: 10.1016/s1092-9134(99)80034-3. Ann Diagn Pathol. 1999. PMID: 10196387

3

Recurrent clear cell carcinoma of the ovary changing into producing parathyroid hormone-related protein (PTH-rP) with hypercalcemia.

Koshiyama M, Fujii H, Konishi M, Nanno H, Hayashi M, Tauchi K, Yoshida M. Koshiyama M, et al. Among authors: fujii h. Eur J Obstet Gynecol Reprod Biol. 1999 Feb;82(2):227-9. doi: 10.1016/s0301-2115(98)00165-1. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10206422

4

Erythrocytosis and a fibroid.

Yoshida M, Koshiyama M, Fujii H, Konishi M. Yoshida M, et al. Among authors: fujii h. Lancet. 1999 Jul 17;354(9174):216. doi: 10.1016/S0140-6736(99)02273-4. Lancet. 1999. PMID: 10421304 No abstract available.

5

Chemosensitivity testing of irinotecan (CPT-11) in ovarian and endometrial carcinomas: a comparison with cisplatin.

Koshiyama M, Fujii H, Kinezaki M, Ohgi S, Konishi M, Hidetaka N, Hayashi M, Yoshida M. Koshiyama M, et al. Among authors: fujii h. Anticancer Res. 2000 May-Jun;20(3A):1353-8. Anticancer Res. 2000. PMID: 10928043

6

Correlation between Topo II alpha expression and chemosensitivity testing for Topo II-targeting drugs in gynaecological carcinomas.

Koshiyama M, Fujii H, Kinezaki M, Yoshida M. Koshiyama M, et al. Among authors: fujii h. Anticancer Res. 2001 Mar-Apr;21(2A):905-10. Anticancer Res. 2001. PMID: 11396183

7

Immunohistochemical expression of topoisomerase IIalpha (Topo IIalpha) and multidrug resistance-associated protein (MRP), plus chemosensitivity testing, as chemotherapeutic indices of ovarian and endometrial carcinomas.

Koshiyama M, Fujii H, Kinezaki M, Morita Y, Nanno H, Yoshida M. Koshiyama M, et al. Among authors: fujii h. Anticancer Res. 2001 Jul-Aug;21(4B):2925-32. Anticancer Res. 2001. PMID: 11712788

8

Ovarian dysgerminoma showing high serum levels and positive immunostaining of placental alkaline phosphatase and neuron-specific enolase associated with elevation of serum prolactin level.

Yoshida M, Koshiyama M, Konishi M, Fujii H, Nanno H, Hayashi M, Kanehira K, Matsuki M, Tauchi K. Yoshida M, et al. Among authors: fujii h. Eur J Obstet Gynecol Reprod Biol. 1998 Oct;81(1):123-8. doi: 10.1016/s0301-2115(98)00162-6. Eur J Obstet Gynecol Reprod Biol. 1998. PMID: 9846727

9

Ovarian actinomycosis complicated by diabetes mellitus simulating an advanced ovarian carcinoma.

Koshiyama M, Yoshida M, Fujii H, Nanno H, Hayashi M, Tauchi K, Kaji Y. Koshiyama M, et al. Among authors: fujii h. Eur J Obstet Gynecol Reprod Biol. 1999 Nov;87(1):95-9. doi: 10.1016/s0301-2115(99)00083-4. Eur J Obstet Gynecol Reprod Biol. 1999. PMID: 10579624

10

Human M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma.

Tani K, Yoshida MC, Satoh H, Mitamura K, Noguchi T, Tanaka T, Fujii H, Miwa S. Tani K, et al. Among authors: fujii h. Gene. 1988 Dec 20;73(2):509-16. doi: 10.1016/0378-1119(88)90515-x. Gene. 1988. PMID: 2854097

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,026 results

Search Page

Filters